Pharmaceutical Ingredient Loteprednol Etabonate CAS 82034-46-6

Product Details
Customization: Available
Powder: Yes
Customized: Non-Customized
Still deciding? Get samples of US$ 50/Piece
Request Sample
Manufacturer/Factory, Other

360° Virtual Tour

Diamond Member Since 2020

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Plant Area
501~1000 square meters
International Commercial Terms(Incoterms)
FOB, EXW, CFR, CIF, DDP, DAP, CIP, Others, FCA
  • Pharmaceutical Ingredient Loteprednol Etabonate CAS 82034-46-6
  • Pharmaceutical Ingredient Loteprednol Etabonate CAS 82034-46-6
  • Pharmaceutical Ingredient Loteprednol Etabonate CAS 82034-46-6
  • Pharmaceutical Ingredient Loteprednol Etabonate CAS 82034-46-6
  • Pharmaceutical Ingredient Loteprednol Etabonate CAS 82034-46-6
  • Pharmaceutical Ingredient Loteprednol Etabonate CAS 82034-46-6
Find Similar Products

Basic Info.

Model NO.
Pharmaceutical Grade
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Children, Adult
State
Solid
Purity
>99%
Loteprednol Etabonate
USP
Transport Package
Drum
Specification
25kg
Trademark
flying deer
Origin
China
Production Capacity
2300 Tons Yearly

Product Description

Pharmaceutical Ingredient Loteprednol Etabonate CAS 82034-46-6
 
Product Name:Loteprednol etabonate CAS:82034-46-6 MF:C24H31ClO7 MW:466.95 EINECS:200-010-0 Mol File:82034-46-6.mol
Melting point:220.5-223.5 Boiling point:600.1±55.0 °C(Predicted) Density 1.31±0.1 g/cm3(Predicted) storage temp. -20°C Freezer solubility DMSO: soluble5mg/mL, clear (warmed) pka14.06±0.70(Predicted) form powder color white to beige Water Solubility <1mg/L(23 ºC)
 
Loteprednol (as Loteprednol Etabonate) is a topical anti-inflammatory corticosteroid. Loteprednol etabonate (LE) has a 17α-chloromethyl ester, in lieu of a ketone group, and a 17β-etabonate group. LE is highly lipophilic and binds with high affinity to the glucocorticoid receptor. Any unbound LE is metabolized to inactive metabolites. Loteprednol etabonate is used in ophthalmic solution for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, uveitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and selected infective conjunctivitis. It is used in ophthalmic ointment for the treatment of post-operative inflammation and pain following ocular surgery. As a nasal spray, it is used for the treatment and management of seasonal allergic rhinitis.

Function :

Common adverse effects include foreign body sensation in the eye, dry eye and epiphora (overflow of tears), chemosis (swelling of the conjunctiva), headache, and itching. Increased intraocular pressure (IOP), a side effect typical of corticosteroids, occurs in about 2% of patients (compared to 7% under acetate, an older anti-inflammatory agent which is prescribed after eye surgery, and 0.5% under placebo). Loteprednol is also far less likely to cause elevated IOP compared to

Application :Loteprednol etabonate is used for the treatment of inflammation of the eye due to allergies,as well as chronic forms of keratitis, vernal keratoconjunctivitis, pingueculitis, and episcleritis.

Pharmaceutical Ingredient Loteprednol Etabonate CAS 82034-46-6
Pharmaceutical Ingredient Loteprednol Etabonate CAS 82034-46-6

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier